País: Reino Unido
Idioma: inglés
Fuente: MHRA (Medicines & Healthcare Products Regulatory Agency)
Cangrelor tetrasodium
Chiesi Ltd
B01AC25
Cangrelor tetrasodium
50mg
Powder for solution for injection
Intravenous
No Controlled Drug Status
Valid as a prescribable product
BNF: